BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11727515)

  • 1. Ongoing trials of immune-based therapies for HIV infection in adults.
    Ross RW; Wright ME; Tavel JA
    Expert Opin Biol Ther; 2001 May; 1(3):413-24. PubMed ID: 11727515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans.
    Ugen KE; Nyland SB; Boyer JD; Vidal C; Lera L; Rasheid S; Chattergoon M; Bagarazzi ML; Ciccarelli R; Higgins T; Baine Y; Ginsberg R; Macgregor RR; Weiner DB
    Vaccine; 1998 Nov; 16(19):1818-21. PubMed ID: 9795386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy and therapeutic vaccines in HIV infection.
    García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune interventions in HIV infection.
    Carcelain G; Autran B
    Immunol Rev; 2013 Jul; 254(1):355-71. PubMed ID: 23772631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic vaccination against HIV: current progress and future possibilities.
    Puls RL; Emery S
    Clin Sci (Lond); 2006 Jan; 110(1):59-71. PubMed ID: 16336205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune-based therapies and HIV infection].
    Weiss L
    Ann Med Interne (Paris); 2002 Jun; 153(4):227-36. PubMed ID: 12218888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A primer on HIV type 1-specific immune function and REMUNE.
    Moss RB; Giermakowska WK; Savary JR; Theofan G; Daigle AE; Richieri SP; Jensen FC; Carlo DJ
    AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S167-75. PubMed ID: 9672235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic vaccines and immunotherapy revisited.
    Gotch F
    J HIV Ther; 2005 Sep; 10(3):48-50. PubMed ID: 16385971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
    Boström AC; Hejdeman B; Matsuda R; Fredriksson M; Fredriksson EL; Bratt G; Sandström E; Wahren B
    Vaccine; 2004 Apr; 22(13-14):1683-91. PubMed ID: 15068851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV gp120 vaccine gene therapy (Wyeth-Lederle Vaccines-Malvern).
    Drugs R D; 1999 Jun; 1(6):448. PubMed ID: 10566079
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune reconstitution in HIV-1-infected patients.
    Imami N; Hardy G; Pires A; Burton C; Pido-Lopez J; Mela C; Gotch F
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1138-45. PubMed ID: 12211404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving immune function and controlling viral replication in HIV-1-infected patients with immune-based therapies.
    Angel JB
    AIDS Read; 2001 Apr; 11(4):209-21. PubMed ID: 11392678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
    Egan MA
    Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
    Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
    J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy.
    Tung FY; Tung JK; Pallikkuth S; Pahwa S; Fischl MA
    Vaccine; 2016 Apr; 34(19):2225-32. PubMed ID: 27002500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing AIDS but not HIV-1 infection with a DNA vaccine.
    Shen X; Siliciano RF
    Science; 2000 Oct; 290(5491):463-5. PubMed ID: 11183769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-adjuvanted HIV-DNA vaccination strategies.
    Lori F; Weiner DB; Calarota SA; Kelly LM; Lisziewicz J
    Springer Semin Immunopathol; 2006 Nov; 28(3):231-8. PubMed ID: 17053912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.
    Boyer JD; Cohen AD; Ugen KE; Edgeworth RL; Bennett M; Shah A; Schumann K; Nath B; Javadian A; Bagarazzi ML; Kim J; Weiner DB
    AIDS; 2000 Jul; 14(11):1515-22. PubMed ID: 10983638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of antiretroviral immunotherapy trials with potentially non-normal and incomplete longitudinal data.
    Mogg R; Mehrotra DV
    Stat Med; 2007 Feb; 26(3):484-97. PubMed ID: 16625520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial.
    Ugen KE; Boyer JD; Wang B; Bagarazzi M; Javadian A; Frost P; Merva MM; Agadjanyan MG; Nyland S; Williams WV; Coney L; Ciccarelli R; Weiner DB
    Vaccine; 1997 Jun; 15(8):927-30. PubMed ID: 9234550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.